India's Serum Institute announces that it will halve the production of its COVID-19 vaccine because it has no new orders for the vaccine
India's Serum Institute announces that it will halve the production of its COVID-19 vaccine because it has no new orders for the vaccine.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthIndia's Serum Institute announces that it will halve the production of its COVID-19 vaccine because it has no new orders for the vaccine
View Premium plansBrowse free archive reportsIndia's Serum Institute announces that it will halve the production of its COVID-19 vaccine because it has no new orders for the vaccine.